By Susanna Moon
Chicago, June 25 - JPMorgan Chase & Co. priced $349,000 of autocallable contingent interest notes due June 30, 2014 linked to Celgene Corp. shares, according to a 424B2 filing with the Securities and Exchange Commission.
The notes will be called at par plus an annualized call premium of 11% if Celgene shares close at or above the initial share price on any quarterly observation date.
If the notes are not called and the final share price is at or above the 70% trigger level, the payout at maturity will be par plus the absolute value of the return.
Otherwise, investors will be fully exposed to any losses.
UBS Financial Services Inc. and J.P. Morgan Securities LLC are the agents.
| Issuer: | JPMorgan Chase & Co.
|
| Issue: | Contingent absolute return autocallable optimization securities
|
| Underlying stock: | Celgene Corp. (NYSE: CELG)
|
| Amount: | $349,000
|
| Maturity: | June 30, 2014
|
| Coupon: | 0%
|
| Price: | Par of $10
|
| Payout at maturity: | If final share price is greater than or equal to trigger price, par plus absolute value of return; otherwise, full exposure to stock decline
|
| Call: | At par plus 11% per year if Celgene stock closes at or above initial share price on any quarterly observation date
|
| Initial share price: | $113.94
|
| Trigger price: | $79.76, 70% of initial share price
|
| Pricing date: | June 21
|
| Settlement date: | June 28
|
| Agents: | UBS Financial Services Inc. and J.P. Morgan Securities LLC
|
| Fees: | 1.5%
|
| Cusip: | 48126H787
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
